Guest Editorial
Volume 10 Issue 8 - 2022
Zoonotic Diseases and the Species Barrier
Shimon Shatzmiller*, Galina Zats, Ludmila Buzhansky, Inbal Lapidot and Rami Krieger
Department of Biological Chemistry, Ariel University, Ariel, Israel
*Corresponding Author: Shimon Shatzmiller, Department of Biological Chemistry, Ariel University, Ariel, Israel.
Received: July 29, 2022; Published: July 29, 2022




Many diseases are transmitted from different animals and other living organisms to humans, including worms, fungi, mammals and reptiles. These are mainly diseases that result from the attack of various microbes on the human body. However, many diseases in animals and plants are not transmitted to humans.

These diseases, such as the “avian flu”, malaria, bilharzia, rabies, the neurological “mad-cow” disease, and recently the coronavirus (COVID-19), originate from animals. And humans are infected with them from these animals. Combating microbes shows that these almost uncurable diseases arise from the entry of the microbes into the human body. The complications caused, in many cases due to a failure of the immune system, are a source of concern. To this day, the Ahoshi race has managed to maintain its existence. But the microbial talent of rapid genetic changes and the creation of mutations. The complexities of the human immune system. They are a significant challenge to the laws and the developers of drugs, vaccines, and other drugs. Only the unification of forces and the transfer of knowledge between the people of Eden can overcome these attacks of the various microbes. But even these days, diseases such as the flu, malaria, and mad cow disease remain, with only partial solutions.

References

  1. SS Morse. "Factors in the emergence of infectious diseases". Emerging Infectious Diseases 1 (1995): 7-15.
  2. Albert Osterhaus. "Catastrophes after crossing species barriers". Philosophical Transactions of the Royal Society B 356 (2001): 791-793.
  3. Jean C Manson and Abigail B Diack. "Evaluating the Species Barrier". ©2016 Food Safety Commission, Cabinet Office, Government of Japan (2016).
  4. Will RG., et al. “A new variant of Creutzfeldt-Jakob disease in the UK”. Lancet 347 (1996): 921-925.
  5. McGovern G., et al. “Influence of breed and genotype on the onset and distribution of infectivity and disease-associated prion protein in sheep following oral infection with the bovine spongiform encephalopathy agent”. Journal of Comparative Pathology 152 (2015): 28-40.
  6. Rubenstein R and Chang B. “Re-assessment of PrPSc distribution in sporadic and variant CJD”. PLoS ONE 8 (2013): e66352.
  7. Wadsworth JDF., et al. “Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay”. The Lancet 358 (2001): 171-180.
  8. Ramasamy I., et al. “Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease”. The Lancet Infectious Diseases 3 (2003): 214-222.
  9. Franz M., et al. “Detection of PrPSc in peripheral tissues of clinically affected cattle after oral challenge with bovine spongiform encephalopathy”. Journal of General Virology 93 (2012): 2740-2748.
  10. Houston F., et al. “Transmission of BSE by blood transfusion in sheep”. Lancet 356 (2000): 999-1000.
  11. Hunter N., et al. “Transmission of prion diseases by blood transfusion”. Journal of General Virology 83 (2002): 2897-2905.
  12. Baeten LA., et al. “A natural case of chronic wasting disease in a free-ranging moose (Alces alces shirasi)”. Journal of Wildlife Diseases 43 (2007): 309-314.
  13. McCutcheon S., et al. “All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD”. PLoS One 6 (2011): e23169.
  14. Andréoletti O., et al. “Highly efficient prion transmission by blood transfusion”. PLOS Pathogens 8 (2012): e1002782.
  15. Hewitt PE., et al. “Three reported cases of variant Creutzfeldt-Jakob disease transmission following transfusion of labile blood components”. Vox Sanguinis 91 (2006): 348.
  16. Peden AH., et al. “Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient”. Lancet 364 (2004): 527-529.
  17. Andréoletti O., et al. “Highly efficient prion transmission by blood transfusion”. PLOS Pathogens 8 (2012): e1002782.
  18. Angers RC., et al. “Chronic wasting disease prions in elk antler velvet”. Emerging Infectious Diseases 15 (2009): 696-703.
  19. Race B., et al. “Prion infectivity in fat of deer with chronic wasting disease”. Journal of Virology 83 (2009): 9608-9610.
  20. Mathiason CK., et al. “Infectious prions in the saliva and blood of deer with chronic wasting disease”. Science5796 (2006): 133-136.
  21. Dhama K., et al. “SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus”. Travel Medicine and Infectious Disease (2020).
  22. Nicole Nova. "Cross-Species Transmission of Coronaviruses in Humans and Domestic Mammals, What Are the Ecological Mechanisms Driving Transmission, Spillover, and Disease Emergence?" Frontiers in Public Health 9 (2021): 717941.
  23. Kumar R., et al. “COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2”. Current Pharmaceutical Design9 (2021): 1194-1201.
  24. World Health Organization (WHO) (2020a) Coronavirus Disease 2019 (COVID-19) Situation Report (2020).
  25. Lai CC., et al. “Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths”. Journal of Microbiology, Immunology and Infection 53 (2020): 404-412.
  26. Wu JT., et al. “Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China”. Nature Medicine 26 (2020): 506-510.
  27. Rosenbaum L. “Facing COVID-19 in Italy-Ethics, Logistics and Therapeutics on the epidemic's front line”. The New England Journal of Medicine 382 (2020): 1873-1875.
  28. Rajgor DD., et al. “The many estimates of the COVID-19 case fatality rate”. The Lancet Infectious Diseases 20 (2020): 776-777.
  29. World Health Organization (WHO) (2020b) COVID-19 Situation Report-142 (2020).
  30. Griffin JF. “A strategic approach to vaccine development: Animal models, monitoring vaccine efficacy, formulation and delivery”. Advanced Drug Delivery Reviews 54 (2002): 851-861.
  31. Gralinski LE and Menachery VD. “Return of the coronavirus: 2019-nCoV”. Viruses 12 (2020): 135.
  32. Muhamood Moothedath., et al. “COVID and Animal Trials: A Systematic Review". Journal of Pharmacy and Bioallied Sciences1 (2021): S31-S35.
Citation: Shimon Shatzmiller., et al. “Zoonotic Diseases and the Species Barrier”. EC Pharmacology and Toxicology 10.8 (2022): 44-48.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 23, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.